Suppr超能文献

针刺治疗糖尿病胃轻瘫的疗效:一项对照初步研究。

Benefits of acupuncture for diabetic gastroparesis: a comparative preliminary study.

机构信息

The Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, , Haifa, Israel.

出版信息

Acupunct Med. 2014 Apr;32(2):139-45. doi: 10.1136/acupmed-2013-010465. Epub 2013 Dec 9.

Abstract

OBJECTIVES

The aim of this preliminary study was to compare the effectiveness of domperidone and acupuncture for the management of diabetic gastroparesis.

METHODS

This was a preliminary, prospective non-randomised, unblinded case-crossover study conducted in patients with longstanding, uncontrolled diabetes mellitus and gastroparesis. All patients received domperidone (20 mg four times a day) for 12 weeks, followed by a 2-3 week washout period, and then biweekly acupuncture treatments for 8 weeks. Gastric emptying rate, glucose and glycated haemoglobin (HbA1C) levels were measured at start and end of each treatment period. At each of these timepoints patients completed the Gastroparesis Cardinal Symptom Index (GCSI), the Satisfaction with Life Scale (SWLS), and the Short-Form 36 Health Survey Update (SF-36).

RESULTS

The trial was curtailed after only eight participants could be recruited in 3 years. The mean age of patients was 57.1±9.9 years, the male:female ratio was 1:7 and mean body mass index (kg/m(2)) was 25.2±1.2. There was no change in any of the outcome parameters after treatment with domperidone. Acupuncture was associated with a decrease in scores for almost all cardinal symptoms of the GCSI, as well as in increased total score on the SWLS (p=0.002) and the social functioning domain of the SF-36 (p=0.054). Acupuncture did not lead to an improvement in gastric emptying, or glucose control from baseline.

CONCLUSIONS

Acupuncture treatment may lead to symptomatic improvement in patients with diabetic gastroparesis. Within the limitations of this preliminary, non-randomised and unblinded study, it appears that this effect may be due to non-specific mechanisms.

摘要

目的

本初步研究旨在比较多潘立酮和针刺治疗糖尿病胃轻瘫的效果。

方法

这是一项初步的、前瞻性的、非随机的、非盲的病例交叉研究,纳入了长期、未控制的糖尿病合并胃轻瘫的患者。所有患者接受多潘立酮(20mg,每日 4 次)治疗 12 周,随后进行 2-3 周的洗脱期,然后接受 8 周的双周针刺治疗。在每个治疗期的开始和结束时测量胃排空率、血糖和糖化血红蛋白(HbA1C)水平。在这些时间点,患者完成了胃轻瘫 Cardinal 症状指数(GCSI)、生活满意度量表(SWLS)和 36 健康调查简表更新版(SF-36)。

结果

该试验在 3 年内仅招募了 8 名患者后就被中止。患者的平均年龄为 57.1±9.9 岁,男女比例为 1:7,平均体重指数(kg/m2)为 25.2±1.2。多潘立酮治疗后,没有任何结果参数发生变化。针刺治疗与 GCSI 的几乎所有主要症状评分降低有关,SWLS 总分(p=0.002)和 SF-36 的社会功能领域评分(p=0.054)升高。针刺治疗并未导致胃排空或血糖控制从基线改善。

结论

针刺治疗可能会改善糖尿病胃轻瘫患者的症状。在这项初步的、非随机的、非盲的研究的限制内,似乎这种效果可能是由于非特异性机制所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验